Conference Date: 24 Nov 2010
Conference Ref: TD A11-1210
Fee: £425 + VAT
Venue: The Rembrandt Hotel, London
PART OF THE PHARMACOKINETICS & PHARMACODYNAMICS TRAINING DAYS 2010 -
3 new training days to deliver high quality training for restricted budgets
See also:
Pharmacokinetics & Dynamics in Early Clinical Development - TD A11-1010 - 22nd November
Drug Switchability & Population PK/PD – TD A11-1110 – 23rd November
Book 2 days at a discounted rate of £765 + VAT
Book all 3 days for only £1,085 + VAT
Why You Should Attend
The presentations will provide information on the use of preclinical pharmacokinetic data in drug discovery and drug development and how these are applied in the assessment and prediction of potential human efficacy and safety. The talks will consider aspects of physicochemistry in drug design as well as the regulatory requirements and expectations for preclinical pharmacokinetics. There is sufficient flexibility within the programme to provide opportunity for discussion such that particular issues may be considered in detail.
Who Should Attend
- Directors and staff of pharmaceutical companies, particularly those in:
- Clinical and Preclinical Research Departments
- Toxicology and Drug Safety
- Regulatory Affairs, Registration, Licensing
- Product Managers
- All those interested in the use of pharmacokinetics in drug discovery and development.
This seminar is NOT aimed at the expert pharmacokineticist, although a knowledge of basic kinetic principles would be useful.
Trainer: Don Walker Freelance Drug Metabolism and Pharmacokinetic Expert
Click here to book your place